Utility of Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) in the evaluation
of one-year outcomes of omalizumab treatment in severe allergic asthma

ISSN: 2353-3854

Alergologia Polska - Polish Journal of Allergology Special Issues

Bieżący numer Archiwum Alergologia Polska - Polish Journal of Allergology

Wyszukiwanie

1/2018

Poleć ten artykuł:

Wyślij znajomemu

Skopiuj link:

Udostępnij:

Utility of Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) in the evaluation of one-year outcomes of omalizumab treatment in severe allergic asthma

Data publikacji online: 2018/09/12

Plik artykułu:

- D.7.pdf [0.77 MB]

Pobierz cytowanie

This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.